MedPath

Gait Evaluation in Haemophiliac Patients

Completed
Conditions
Hemophilia A
Hemophilia B
Registration Number
NCT00824798
Lead Sponsor
Cliniques universitaires Saint-Luc- Universit茅 Catholique de Louvain
Brief Summary

Joint damage secondary to recurrent haemarthroses and chronic synovitis represents the commonest clinical manifestation of haemophilia. Incapacitating pain, loss of joint stability and mobility, axial deviation, deterioration and decreased function are the most frequent complains in patients with severe haemophilic arthropathy In this context, the purpose of our study is to examine and analyse specific changes in gait in patients suffering from haemophilic arthropathy and determine the impact on health-related quality of life in terms of conceptual components of pain and stiffness, psychosocial stress, disability, and activity limitations as recommended by the International Classification of Function (ICF) recently published by the World Health Organization.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
31
Inclusion Criteria
  • haemophilia A or B
  • aged more than 4 years
Exclusion Criteria
  • impossibility to walk on a treadmill
  • recent joint haemarthrosis or muscle haematoma

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
evaluate specific changes in gait in patients suffering from haemophilic arthropathyfrom inclusion in the study until 1 year after inclusion
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cliniques universitaires Saint-Luc

馃嚙馃嚜

Brussels, Belgium

漏 Copyright 2025. All Rights Reserved by MedPath